MAPP BIOPHARMACEUTICAL
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense. The company has been developing an Ebola therapy for more than a decade and has been working with the United States and Canadian governments to develop this therapy. Mapp Biopharmaceutical was founded in 2003 by Kevin Whaley and Larry Zeitlin. It is headquartered in San Diego, C.A.
MAPP BIOPHARMACEUTICAL
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.mappbio.com
Total Employee:
11+
Status:
Active
Contact:
(858) 625-0335
Email Addresses:
[email protected]
Total Funding:
16.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Collaborations Pharma
Performs research and development on innovative therapeutics for multiple rare and infectious diseases.
IASO Pharma
IASO Pharma is a development stage company developing therapeutics for the treatment and prevention of infectious diseases.
PharmAkea Therapeutics
PharmAkea is a biopharmaceutical company developing small molecule drug candidates targeting proteins in fibroproliferative diseases.
Qpex Biopharma
Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sorriso Pharmaceuticals
Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
U.S. Department of Health & Human Services
U.S. Department of Health & Human Services investment in Grant - Mapp Biopharmaceutical
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-04-09 | The University of Texas Medical Branch | Mapp Biopharmaceutical investment in Grant - The University of Texas Medical Branch | 35 M USD |
Official Site Inspections
http://www.mappbio.com Semrush global rank: 5.64 M Semrush visits lastest month: 1.5 K
- Host name: cloudproxy10157.sucuri.net
- IP address: 192.124.249.157
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mapp Biopharmaceutical"
Mapp Biopharmaceutical, Inc. - Mapp Biopharmaceutical, Inc.
Oct 27, 2022 · Mapp Biopharmaceutical develops novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on global health and biodefense.See details»
About Us - Mapp Biopharmaceutical, Inc.
May 15, 2024 · Mapp Biopharmaceutical was founded in 2003 by Drs. Kevin Whaley and Larry Zeitlin to develop novel pharmaceuticals for the prevention and treatment of infectious …See details»
Mapp Biopharmaceutical - Crunchbase Company …
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases. View contacts for Mapp Biopharmaceutical to access new leads and connect with decision-makers.See details»
Mapp Biopharmaceutical Inc | LinkedIn
Developing monoclonal antibody drugs for unmet needs in public health and biodefense. Mapp Biopharmaceutical, Inc. is a biotechnology company located in San Diego, California, United States....See details»
Mapp Biopharmaceutical - Wikipedia
Mapp Biopharmaceutical is an American pharmaceutical company founded in 2003 by Larry Zeitlin and Kevin Whaley. Mapp Biopharmaceutical is based in San Diego, California. It is responsible for the research and development of ZMapp, a drug which is still under development and comprises three humanized monoclonal antibodies used as a treatment for Ebola virus disease. The drug was first tested in humans during the 2014 West Africa Ebola virus outbreak. See details»
Contact Us - Mapp Biopharmaceutical, Inc.
May 15, 2024 · BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease As a part of ongoing national …See details»
Overview, News & Similar companies - ZoomInfo.com
Jan 23, 2023 · View Mapp Biopharmaceutical (www.mappbio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Mapp Biopharmaceutical, Inc. | Scientist.com
Mapp Biopharmaceutical was founded in 2003 by Drs. Kevin Whaley and Larry Zeitlin to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on …See details»
Mapp Biopharmaceutical - Craft
See insights on Mapp Biopharmaceutical including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Medical Countermeasures | BARDA collaborates with …
May 14, 2024 · Mapp Biopharmaceutical, Inc. (San Diego, CA) develops novel antibody drugs for the prevention and treatment of infectious disease, focusing on unmet needs in global health and biodefense. Last Updated: May 14, 2024.See details»
ZMapp® FAQ - Mapp Biopharmaceutical, Inc.
May 15, 2024 · ZMapp® is an experimental new therapy that is being developed to treat patients with Ebola. It is comprised of a series of three different monoclonal antibodies that work to …See details»
ProBioGen and Mapp Biopharmaceutical Partner to Develop …
On March 13, 2024, contract development and manufacturing organization (CMDO), ProBioGen, announced that it has entered into services and license agreements with Mapp …See details»
Ebola treatment with ZMapp cocktail expected in 2015
Sep 29, 2014 · Jeffrey Turner, president and CEO of Defyrus, discussed the Ebola outbreak and ZMapp’s potential role on Monday during a web seminar as part of National Biotech Week. …See details»
Mapp Biopharmaceutical | Insights
Feb 26, 2021 · George Scangos made a surprising shift when the former Biogen CEO left the world of big biotech to lead an infectious disease-focused start-up. Vir Biotechnology Inc. …See details»
Medical Countermeasures | BARDA collaborates with Mapp ...
Oct 18, 2022 · Mapp Biopharmaceutical, Inc. (San Diego, CA) develops novel antibody drugs for the prevention and treatment of infectious disease, focusing on unmet needs in global health …See details»
Mapp Biopharmaceutical - HigherGov
Mapp Biopharmaceutical (UEI M9V9QTHR1H28, CAGE 417U0) based in San Diego CA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
bio - Mapp Biopharmaceutical, Inc.
May 15, 2024 · BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease As a part of ongoing national …See details»
MappBio Announces Contract with BARDA for MBP091 as a pan …
SAN DIEGO, June 11, 2019 /PRNewswire/ -- Mapp Biopharmaceutical, Inc. (MappBio), announced today that it has been awarded an advanced research and development contract …See details»
About LeafBio - Mapp Biopharmaceutical, Inc.
LeafBio focuses on pharmaceutical research and development of monoclonal antibody products for the treatment and prevention of viral and infectious diseases (including respiratory, …See details»
News - Mapp Biopharmaceutical, Inc.
Nov 24, 2020 · BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease As a part of ongoing national …See details»